Peer-reviewedCC BY 4.0Journal of Biological Chemistry
Structural mechanism of TRPC3 inhibition by a potent antagonist
Related
- Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses
- Discovery of potent anti-inflammatory flavonoid-sesquiterpenoid hybrids from Syzygium simile: Structure–activity relationships and nanomolar inhibition of human neutrophil activation
- Structural Basis of NR2B-Selective Antagonist Recognition by N-Methyl-d-aspartate Receptors
- Insight into the mechanism of molecular interactions of the NDM metallo-beta-lactamase and cyclic boronate inhibition by molecular docking and molecular dynamics simulations
- Structural and Kinetic Basis for Selective Inhibition of Canine Myeloperoxidase by Staphylococcal Peroxidase Inhibitor (SPIN) Orthologs
BibTeX
@article{collingridge2026structural,
title = {{Structural mechanism of TRPC3 inhibition by a potent antagonist}},
author = {Jodie Collingridge and Bethan A. Cole and Molly A. Rowlett and John Liddle and Kelly M. Gatfield and Philip C. Biggin and EBE. Becker},
journal = {Journal of Biological Chemistry},
year = {2026},
month = oct,
doi = {10.1016/j.jbc.2026.113644},
url = {https://linkinghub.elsevier.com/retrieve/pii/S0021925826025160},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Structural mechanism of TRPC3 inhibition by a potent antagonist
AU - Jodie Collingridge
AU - Bethan A. Cole
AU - Molly A. Rowlett
AU - John Liddle
AU - Kelly M. Gatfield
AU - Philip C. Biggin
AU - EBE. Becker
PY - 2026
DA - 2026/10/01
JO - Journal of Biological Chemistry
DO - 10.1016/j.jbc.2026.113644
UR - https://linkinghub.elsevier.com/retrieve/pii/S0021925826025160
SN - 0021-9258
ER -